Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Endexx Corp - SIC # 2833 - MEDICINAL CHEMICALS AND BOTANICAL PRODUCTS
Ticker
Exchange
SIC #
Website
Latest Ticker
EDXC
Over the counter
2833
https://endexx.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Endexx Corp
Endexx Corporation Reports Substantial Financial Growth and Market Expansion in Annual Financial Results
- Apr 18th, 2024 8:08 pm
Endexx Corporation's HYLA Accelerates Global Reach in Vape Innovation With Strategic Distribution Milestones
- Apr 2nd, 2024 1:00 pm
Endexx Corporation (EDXC) Leverages Global Market Trends and Legislative Reforms to Spearhead Growth in the Cannabis and Plant-Based Wellness Sectors
- Mar 27th, 2024 12:30 pm
Update - Endexx Corporation Embarks on Strategic Transformation: Leadership Evolution and Intensified Focus on HYLA's Market Dominance
- Mar 13th, 2024 3:00 am
Endexx Corporation Embarks on Strategic Transformation: Leadership Evolution and Intensified Focus on HYLA's Market Dominance
- Mar 12th, 2024 12:00 pm
Endexx Corporation Announces Transition to New Auditor Amid Strategic Evolution
- Mar 1st, 2024 2:00 pm
Endexx Corporation Announces Strategic Shift in Auditor Services to Bolster Growth and Transparency
- Feb 16th, 2024 3:00 pm
Endexx Ushers in a New Era: Strategic Refresh With Executive and Board Enhancements
- Jan 17th, 2024 2:30 pm
Endexx Initiates TPD Registration in Europe
- Nov 14th, 2023 1:30 pm
Endexx Shareholder Update Highlights Projected Momentum and Growth Rate for 2024
- Nov 1st, 2023 5:56 pm
Endexx Featured on Small Cap Voice
- Nov 1st, 2023 12:30 pm
Endexx Announces Strategic Partnership With Italy-Based Marketing Firm XVI Ventures
- Oct 19th, 2023 12:00 pm
Endexx Secures Reorder for Non-Nicotine Vape Product HYLA From Italy
- Oct 12th, 2023 12:00 pm
Endexx Announces Amended Consolidated 10-Q/A: Quarterly Report for The Quarter Ending March 31, 2023, Increasing Year-Over-Year 1013%
- Sep 19th, 2023 12:30 pm
Endexx Announces Company Presentation in Michigan on October 2nd, 2023
- Sep 13th, 2023 12:30 pm
Endexx Provides Insight on Possible New Federal Cannabis Regulations
- Sep 12th, 2023 12:30 pm
Endexx Corporation Appoints Ahmed Itani to Director of Marketing of HYLA in The Middle East Region
- Sep 6th, 2023 12:30 pm
Endexx Secures $2.0M Purchase Order for Non-Nicotine Vape Product HYLA From Sahara Trading UAE
- Aug 9th, 2023 12:30 pm
Endexx Corporation Announces Live Twitter Spaces Q/A & Fireside Chat with C-Suite
- Aug 4th, 2023 10:38 pm
Endexx Corporation Announces Uplisting to OTCQB Venture Market
- Jul 31st, 2023 12:30 pm
Scroll